Pharma giant and guitar maker to roll out SAP

News

Pharma giant and guitar maker to roll out SAP

Daniel Thomas
Pharmaceutical giant Novartis is planning a wide-ranging SAP implementation to support its global strategy of unifying people, business processes, information and IT systems across its worldwide operations.

The SAP for Pharmaceuticals suite will replace legacy systems at Novartis offices in more than 50 countries around the globe, with the aim of creating efficiencies for research and development, administration, and managing human resources, supplier relationships, production and supply chain processes.

By incrementally deploying mySAP Business Suite applications, including human resources, supplier relationship management and supply chain management, Novartis aims to drive down integration costs and reduce total cost of ownership.

The industry-specific functionality in the SAP for Pharmaceuticals portfolio will also allow Novartis to comply with 21 CFR Part 11, the regulations on electronic records and signatures for the pharmaceutical industry set by the US Food and Drug Administration.

Fender Musical Instruments is also rolling out the mySAP Business Suite, to integrate its IT systems and serve as a platform for future growth.

The company, a famous maker of guitars, amplifiers and musical equipment, will replace a plethora of legacy systems with SAP modules, including supply chain management financials and CRM.

It hopes the systems will help it to streamline its distribution and warehouse systems, facilitate expansion into new markets and improve customer service.

The implementation, which will be overseen by SAP Consulting, will begin in July.

The announcements were made at Sapphire 03, SAP's international customer conference, being held in Orlando this week.


Email Alerts

Register now to receive ComputerWeekly.com IT-related news, guides and more, delivered to your inbox.
By submitting you agree to receive email from TechTarget and its partners. If you reside outside of the United States, you consent to having your personal data transferred to and processed in the United States. Privacy
 

COMMENTS powered by Disqus  //  Commenting policy